Clinical Trial Update: Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A [Phase 3]

View source ↗

Summary

Phase 3 trial update on a GlaxoSmithKline pneumococcal conjugate vaccine (1024850A) reporting its immunogenicity, safety, and impact on carriage and acute otiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media
• Streptococcal Infections
• Streptococcus Pneumoniae Infections

Drugs mentioned

• Pneumococcal conjugate vaccine 1024850A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal, Streptococcus Pneumoniae | Phase 3 | Status: COMPLETED | Results posted: 2020-07-27